Dogwood Therapeutics (DWTX) Market Capitalization (2020 - 2026)

Dogwood Therapeutics has reported Market Capitalization for 7 years, with the latest figure at $54.1 million in Q2 2026.

• On a quarterly basis, Market Capitalization rose 493.93% year-over-year to $54.1 million in Q2 2026; TTM through Jun 2026 was $54.1 million, a 493.93% increase from a year earlier, with the FY2025 full-year figure at $20.7 million, up 709.09% from the prior year.
• Market Capitalization was $54.1 million for Q2 2026 at Dogwood Therapeutics, down from $70.5 million in the prior quarter.
• The five-year high for Market Capitalization was $70.5 million in Q1 2026, with the low at $2.6 million in Q4 2024.
• Average Market Capitalization over 5 years is $18.9 million, with a median of $10.2 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Market Capitalization slumped 93.87% in 2022, then surged 875.86% in 2026.
• Over 5 years, Market Capitalization stood at $2.6 million in 2022, then surged by 323.85% to $11.1 million in 2023, then tumbled by 76.89% to $2.6 million in 2024, then jumped by 709.09% to $20.7 million in 2025, then jumped by 161.49% to $54.1 million in 2026.
• The last three Market Capitalization figures came in at $54.1 million (Q2 2026), $70.5 million (Q1 2026), and $20.7 million (Q4 2025), per Business Quant data.